Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (40)	6/4/1998 12:26:00 PM
From: Cage Rattler	Respond to of 5402

Curtis: I'm not "overly bullish." SGNC is a penny stock that may to have a better than average risk to reward ratio -- which of course is a judgment call. Ciao, Ted

To: chirodoc who wrote (40)	6/4/1998 1:48:00 PM
From: Gwolf	Read Replies (1) \| Respond to of 5402

Chirodoc, All of the other competitors have pulled out to the best of my knowledge. Everyone else was trying to use an animal blood derivative, the problem is with the proteins. If you look at various forms of research you see that proteins are linked to cancer, alzheimer's, mad cow disease and various other maladies. So any other competition has been dropped at this time. Their original product had a patent, however the current product has been improved upon enough that is now requires a new patent. How did you figure the company is in financial straits ? Please explain. Gwolf